Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

ANI PHARMACEUTICALS, INC.

(ANIP)
Prezzo in differita. Tempo differito Nasdaq - 15/10 22:00:01
38.54 USD   +2.17%
2013ANI PHARMACEUTICALS INC: REVERSE SPLIT: 1 per 6
FA
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioniDerivati 
RiassuntoTutte le notizieAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Notizie in altre lingue su ANI PHARMACEUTICALS, INC.
20/09ANI PHARMACEUTICALS: to Present at Cantor Virtual Global Healthcare Conference 2021
17/09ANI PHARMACEUTICALS: Launches Generic Hypertension Drug
17/09ANI PHARMACEUTICALS: Announces Launch of Nebivolol Tablets
17/09ANI Pharmaceuticals, Inc. Announces Launch of Nebivolol Tablets
31/08ANI PHARMACEUTICALS: Says FDA Accepts for Review Its Supplemental New Drug Application fo..
31/08ANI PHARMACEUTICALS: FDA Accepts Application for Cortrophin Gel Revival
31/08ANI PHARMACEUTICALS: Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental Ne..
31/08Ani Pharmaceuticals Announces FDA Acceptance of Purified Cortrophin® Gel Supplemental N..
06/08ANI PHARMACEUTICALS: Posts Lower Q2 Earnings, Revenue Increases
06/08ANI PHARMACEUTICALS: Management's Discussion and Analysis of Financial Condition and Resu..
06/08ANI PHARMACEUTICALS INC: Results of Operations and Financial Condition, Financial Stateme..
06/08Ani Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended June 30..
06/08ANI: Q2 Earnings Snapshot
06/08ANI PHARMACEUTICALS: Earnings Flash (ANIP) ANI PHARMACEUTICALS Reports Q2 Revenue $48.6M,..
06/08ANI PHARMACEUTICALS: Reports Second Quarter 2021 Results
06/08ANI PHARMACEUTICALS: Earnings Flash (ANIP) ANI PHARMACEUTICALS Posts Q2 EPS $0.67, vs. St..
06/08NORTH AMERICAN MORNING BRIEFING: Stock Futures -2-
22/07ANI PHARMACEUTICALS: to Discuss Second Quarter 2021 Financial Results on August 6, 2021
06/07ANI PHARMACEUTICALS: Resubmits Supplemental New Drug Application for Cortrophin Gel
06/07ANI PHARMACEUTICALS: Announces Refiling of Cortrophin sNDA with FDA
25/06ANI PHARMACEUTICALS, INC.(NASDAQGM: ANIP) dropped from Russell 2500 Growth Index
25/06ANI PHARMACEUTICALS, INC.(NASDAQGM: ANIP) dropped from Russell 2000 Growth Index
25/06ANI PHARMACEUTICALS, INC.(NASDAQGM: ANIP) dropped from Russell Small Cap Comp Growth Inde..
25/06ANI PHARMACEUTICALS, INC.(NASDAQGM: ANIP) dropped from Russell 3000 Growth Index
25/06ANI PHARMACEUTICALS, INC.(NASDAQGM: ANIP) dropped from Russell Microcap Growth Index
25/06ANI PHARMACEUTICALS, INC.(NASDAQGM: ANIP) dropped from Russell 3000E Growth Index
15/06ANI PHARMACEUTICALS: to Present at the Raymond James Human Health Innovation Conference 2..
04/06ANI PHARMACEUTICALS INC: Submission of Matters to a Vote of Security Holders, Regulation ..
01/06ANI PHARMACEUTICALS: Announces Details of 2021 Virtual Annual Meeting of Stockholders
27/05ANI PHARMACEUTICALS: to Present at Jefferies Virtual Healthcare Conference 2021
07/05ANI PHARMACEUTICALS: Management's Discussion and Analysis of Financial Condition and Resu..
07/05ANI PHARMACEUTICALS INC: Results of Operations and Financial Condition, Financial Stateme..
07/05ANI PHARMACEUTICALS: Q1 Adjusted Earnings Remain Unchanged, Revenue Grows
07/05ANI: Q1 Earnings Snapshot
07/05ANI PHARMACEUTICALS: Earnings Flash (ANIP) ANI PHARMACEUTICALS Reports Q1 Revenue $54.5M,..
07/05ANI PHARMACEUTICALS: Reports First Quarter 2021 Results
07/05ANI PHARMACEUTICALS: Earnings Flash (ANIP) ANI PHARMACEUTICALS Posts Q1 EPS $1.04, vs. St..
07/05Ani Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31..
26/04ANI PHARMACEUTICALS: to Discuss First Quarter 2021 Financial Results on May 7, 2021
06/04ANI PHARMACEUTICALS INC: Regulation FD Disclosure, Financial Statements and Exhibits (for..
06/04ANI PHARMACEUTICALS: Acquires New Drug Applications From Sandoz
06/04ANI PHARMACEUTICALS: Expands Branded Products Portfolio Through Acquisition of Sandoz Inc..
06/04ANI Pharmaceuticals, Inc. acquired Portfolio of NDAs and ANDA of Sandoz Inc. for $20.7 ..
30/03INSIDER TRENDS: ANI Pharmaceuticals Insider Sells Stock for Taxes Interrupting 90-Day Buy..
18/03INSIDER TRENDS: 90-Day Buying Trend Extended with Insider Purchase of ANI Pharmaceuticals..
11/03ANI PHARMACEUTICALS: Management's Discussion and Analysis of Financial Condition and Resu..
09/03ANI PHARMACEUTICALS INC: Entry into a Material Definitive Agreement, Unregistered Sale of..
09/03ANI PHARMACEUTICALS: Q4 Adjusted Earnings Drop, Revenue Rises; Acquires Novitium Pharma f..
09/03ANI PHARMACEUTICALS INC: Results of Operations and Financial Condition, Financial Stateme..
09/03ANI Pharmaceuticals Provides Standalone Earnings Guidance for the Year 2021
09/03ANI: Q4 Earnings Snapshot
09/03ANI PHARMACEUTICALS: Earnings Flash (ANIP) ANI PHARMACEUTICALS Posts Q4 Revenue $57.3M, v..
09/03ANI PHARMACEUTICALS: Earnings Flash (ANIP) ANI PHARMACEUTICALS Posts Q4 EPS $0.80, vs. St..
09/03ANI PHARMACEUTICALS: Reports Fourth Quarter and Full Year 2020 Results; Company Positione..
09/03ANI Pharmaceuticals, Inc. Reports Intangible Asset Impairments Change for the Fourth Qu..
09/03Ani Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended Decembe..
09/03ANI PHARMACEUTICALS: to Acquire Novitium Pharma, Strengthening R&D Engine and Expanding G..
09/03ANI Pharmaceuticals, Inc. signed a definitive agreement to acquire Novitium Pharma LLC ..
08/03ANI Pharmaceuticals, Inc. announced that it expects to receive $25 million in funding f..
19/02ANI PHARMACEUTICALS: Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/02ANI PHARMACEUTICALS INC: Change in Directors or Principal Officers, Regulation FD Disclos..
17/02ANI PHARMACEUTICALS: Strengthens Leadership Team to Accelerate Future Growth
17/02ANI Pharmaceuticals Strengthens Leadership Team to Accelerate Future Growth
16/02ANI PHARMACEUTICALS: to Discuss Fourth Quarter and Full Year 2020 Financial Results on Ma..
01/02ANI PHARMACEUTICALS: Announces Launch of Prazosin Hydrochloride (“HCl”) Capsu..
01/02ANI Pharmaceuticals, Inc. Announces Launch of Prazosin Hydrochloride Capsules
2020ANI PHARMACEUTICALS: Launches Aminocaproic Acid Tablets Following FDA Approval
2020ANI PHARMACEUTICALS: Announces Approval and Launch of Aminocaproic Acid Tablets
2020ANI Pharmaceuticals, Inc. Announces Approval and Launch of Aminocaproic Acid Tablets
2020INSIDER TRENDS: Insider Purchase Adds to ANI Pharmaceuticals Positive Trend
2020ANI: 3Q Earnings Snapshot
2020ANI PHARMACEUTICALS: Management's Discussion and Analysis of Financial Condition and Resu..
2020ANI PHARMACEUTICALS INC: Results of Operations and Financial Condition, Financial Stateme..
2020Ani Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter Ended Septembe..
2020ANI PHARMACEUTICALS: Earnings Flash (ANIP) ANI PHARMACEUTICALS Reports Q3 EPS $0.97, vs. ..
1  2  3  4  5  6Pross.
Prossimo evento su ANI PHARMACEUTICALS, INC.
10/11/21
Prossimi eventi del settore